Cargando…
Fecal Microbiota Transplantation in Recurrent Clostridium Difficile Infection: Is it Superior to Other Conventional Methods?
Clostridium difficile (C. difficile) is a gram-positive species of spore-forming bacteria. C. difficile infection (CDI) is one of the most common hospital-acquired infections in the United States, mainly caused by the use of recent antibiotics that leads to intestinal dysbiosis. Recurrent C. diffici...
Autores principales: | Lin, Zayar, Iqbal, Zafar, Ortiz, Juan Fernando, Khan, Sawleha Arshi, Jahan, Nusrat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482981/ https://www.ncbi.nlm.nih.gov/pubmed/32923252 http://dx.doi.org/10.7759/cureus.9653 |
Ejemplares similares
-
Post-Marketing Experience of Edaravone in Amyotrophic Lateral Sclerosis: A Clinical Perspective and Comparison With the Clinical Trials of the Drug
por: Ortiz, Juan Fernando, et al.
Publicado: (2020) -
Fecal Microbiota Transplant in Recurrent Clostridium Difficile Infections: A Systematic Review
por: Gupta, Kunal, et al.
Publicado: (2022) -
How to Treat Asymptomatic and Symptomatic Urinary Tract Infections in the Kidney Transplant Recipients?
por: Iqbal, Zafar, et al.
Publicado: (2020) -
Effectiveness of Fecal Microbiota Transplantation Treatment in Patients With Recurrent Clostridium difficile Infection, Ulcerative Colitis, and Crohn’s Disease: A Systematic Review
por: Jaramillo, Arturo P, et al.
Publicado: (2023) -
Lyophilized Fecal Microbiota Transplantation Capsules for Recurrent Clostridium difficile Infection
por: Dupont, Hebert, et al.
Publicado: (2017)